Category: Healthcare


Federal regulators are warning consumers and the medical community that a potentially life-threatening condition called diabetic ketoacidosis may be linked to a popular class of diabetes drugs known as SGLT2 (sodium-glucose cotransporter-2) inhibitors.

Recent studies suggest that use of the popular new age drugs known as SGLT2 Inhibitors used to treat type 2 diabetes show links to deadly side effects including DKA or diabetic ketoacidosis, kidney failure, heart attack and stroke.